Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results
Nov 01, 2016 20:05 pm UTC| Business
Total Revenues of $177.5 MillionAdjusted EPS of $0.23 and Diluted EPS of ($0.02)Company Maintains Fiscal Year 2017 Financial Guidance and Issues Fiscal Second-Quarter 2017 Financial Guidance SALT LAKE CITY, Nov. 01,...
Five9 Reports Third Quarter Total Revenue Growth of 27%
Nov 01, 2016 20:05 pm UTC| Business
LTM Enterprise Subscription Revenue Growth Accelerates to 43% YTD GAAP Operating Cash Flow Improves by $16.9MRaises 2016 Guidance for Revenue and Bottom LineSAN RAMON, Calif., Nov. 01, 2016 -- Five9, Inc. (NASDAQ:FIVN),...
Intellia Therapeutics Reports Financial Results for Third Quarter 2016
Nov 01, 2016 20:05 pm UTC| Business
First company to report high in vivo editing data using CRISPR/Cas9 in animal modelsFurther validation of lipid nanoparticle delivery platformEnded quarter with $290.6 million in cash and cash equivalents CAMBRIDGE,...
Frank’s International Completes Previously Announced Acquisition of Blackhawk Specialty Tools
Nov 01, 2016 20:05 pm UTC| Business
HOUSTON, Nov. 01, 2016 -- Frank’s International N.V. (“Frank’s”) (NYSE:FI) announced today that it has completed the acquisition of Blackhawk Group Holdings, Inc., the ultimate parent company of Blackhawk Specialty...
TRACON to Report Third Quarter 2016 Company Highlights and Financial Results on November 8, 2016
Nov 01, 2016 20:05 pm UTC| Business
SAN DIEGO, Nov. 01, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Kura Oncology to Participate in Two Upcoming Investor Conferences
Nov 01, 2016 20:05 pm UTC| Business
LA JOLLA, Calif., Nov. 01, 2016 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to...
Nov 01, 2016 20:05 pm UTC| Business
NASHVILLE, Tenn., Nov. 01, 2016 -- Healthways (NASDAQ:HWAY) today announced that Glenn Hargreaves, the Company’s longtime Chief Accounting Officer, has been appointed by the Healthways Board of Directors as interim CFO,...